Suchergebnisse - Spiessens, Bart*

1

Clinical presentation and antimicrobial resistance of invasive Escherichia coli disease in hospitalized older adults: a prospective multinational observational study

von: Doua, Joachim

2024, in: Infection

Wird geladen...
2

Unbiased identification of risk factors for invasive Escherichia coli disease using machine learning

von: Clarke, Erik

2024, in: BMC infectious diseases

Wird geladen...
3

Statistical Practice - Conditional Linear Mixed Models

von: Verbeke, Geert

2001, in: The American statistician

Wird geladen...
4

Feasibility of tracking invasive Escherichia coli disease among older adults in a community setting: A prospective observational study

von: Doua, Joachim

2024, in: European journal of clinical microbiology & infectious diseases

Wird geladen...
5

The Practical Use of Different Strategies to Handle Dropout in Longitudinal Studies

von: Verbeke, Geert

2001, in: Therapeutic innovation & regulatory science

Wird geladen...
6

Harmonizing the collection of solicited adverse events in prophylactic vaccine clinical trials

von: Brigitte Cheuvart

2023, in: Expert Review of Vaccines

Wird geladen...
7

Characterization of Escherichia coli isolates potentially covered by ExPEC4V and ExPEC10V, that were collected from post-transrectal ultrasound-guided prostate needle biopsy invasive urinary tract and bloodstream infections

von: Saade, Elie

2020, in: Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement

Wird geladen...
8

Safety and immunogenicity of a vaccine for extra-intestinal pathogenic

von: Frenck, Robert W

2019, in: The lancet / Infectious diseases

Wird geladen...
9

Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate

von: Ramon Roozendaal

2020, in: npj Vaccines

Wird geladen...
10

Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo

von: Deborah Watson-Jones

2022, in: BMJ Open

Wird geladen...
11

MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial

von: Dreno, Brigitte

2018, in: My

Wird geladen...
12

Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola

von: Viki Bockstal

2022, in: npj Vaccines

Wird geladen...
13

Marginalized Multilevel Models and Likelihood Inference - Comment

von: Lesaffre, Emmanuel

2000, in: Statistical science

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!